Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date: May 21, 2013
Event: Disclosure of a presentation by the CEO and CFO at the UBS Global Healthcare Conference.
Key Financial Metrics
This filing does not contain specific financial data. The document serves as a notice that presentation slides (Exhibit 99.1) were furnished to investors. The filing explicitly states that the information in the slides is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, no revenue, profit, cash flow, margin, debt, or liquidity figures are provided in this text.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the occurrence of an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: Joseph DeVivo (CEO) and Mark Frost (CFO) presented to investors. The content of their commentary is contained in the attached slides, which are not incorporated by reference into this filing.
Risks and Contingencies: The filing includes a standard disclaimer that the presentation materials are not subject to the liabilities of Section 18 of the Securities Exchange Act of 1934. No specific new risks or contingencies are detailed in the text of this report.
Investor Verification Checklist
- Verify the content of the presentation slides (Exhibit 99.1) for specific financial guidance or operational updates, as they are not included in the main text of this 8-K.
- Confirm that the presentation materials are not legally considered "filed" documents for liability purposes under Section 18.
- Review subsequent filings (e.g., 10-Q or 10-K) for audited or reviewed financial data corresponding to the period discussed in the presentation.